Calidi Biotherapeutics, Inc. (CLDI)
$0.95-7.77%Close
SELLCRISIS · day 71
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $7M
- Beta
- 1.33
- P/E (TTM)
- -0.02
- Short % float
- 4.24%
- Days to cover
- 1.0
- SI change
- +2.4%
- 1W
- -9.52%
- 1M
- -23.39%
- vs SPY 1W
- -9.95%
- vs SPY 1M
- -25.45%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
ANALYST & RATINGS
LOADING…Loading analyst data…
Company news
FAQ
- What is LOPJLB’s current signal on CLDI?
- LOPJLB’s latest quantitative signal on Calidi Biotherapeutics, Inc. (CLDI) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is CLDI in?
- Calidi Biotherapeutics, Inc. (CLDI) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Calidi Biotherapeutics, Inc. (CLDI) do?
- Calidi Biotherapeutics, Inc. is a clinical-stage biotechnology company focused on immuno-oncology, dedicated to developing advanced immunotherapies for various cancers. The company's innovative approach centers on utilizing powerful, allogeneic (donor-derived) stem cells as specialized carriers for anti-tumor agents. This technology is being advanced to address a range of oncological conditions…